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1INTRODUCTION
Supraglottic airway devices are devices that ventilate  patients by
delivering anaesthetic gases and oxygen above the level of vocal cords
thereby avoiding the disadvantages of endotracheal intubation.
Supraglottic airway devices have the advantages of avoiding
laryngoscopy, better tolerance by the patients, lesser hemodynamic
perturbations, lesser invasiveness of the respiratory tract, easier
placement of the device, airway free from manipulation, lesser
complications like sore throat and easier, quicker control of airway even
by inexperienced personal.
 Laryngeal mask airway is a type of Supraglottic airway device,
invented and designed by Dr.Archie I J Brain in London in 1981. Since
then it had been used in over 300 million patients worldwide.
The LMA-Classic was introduced into clinical practice since
1988. LMA Classic is an autoclavable laryngeal mask airway which can
be reused. It consists of an airway tube which is connected to an
inflatable mask with a silicone rim. The LMA Classic, available in
sizes 1 to 6, is designed to fit most airways, from neonates through large
adults; it is reusable up to 40 times with steam autoclaving. Many
2different variants of Classic-LMA have been introduced following its
success and popularity. AMBU LMA is one among the variants.
The AMBU LMA is a single use disposable Supraglottic airway
device manufactured from polyvinyl chloride. It consists of three main
elements which include an airway tube, a mount member and a cuff. The
device has a bent forming an angle of 90° which makes it easier to insert
as it conforms the human airway anatomy. The cuff is thin and fits well
with the hypopharynx. Positioning the cuff properly, places the cuff
over the upper oesophageal sphincter and at the base of the tongue rests
the proximal end of the cuff. The AMBU LMA does not have aperture
bars, meaning the bowl is open and it faces the glottis.
With this background this study was conceptualized to compare
the performance of LMA-Classic and LMA-AMBU in minor
Gynaecological surgeries.
3ANATOMY OF THE UPPER AIRWAY
  The upper airway consists of the following components
1. Nasal cavity
2. Oral cavity
3. Nasopharynx
4. Oropharynx
5. larynx
Nasal cavity:
 The nose warms, filters and humidifies incoming air and is  the
organ of smell. The nasal cavities extend from naris to the end of the
turbinates.
The nasal cavities are divided by the nasal septum. The
cribriform plate of ethmoid bone forms the roof of the nasal cavity.
From the bony lateral wall of  the nasal cavity, originates  three
turbinates which project into the nasal cavity.
ANATOMY OF THE UPPER AIRWAY
4Openings in the lateral wall communicate with the paranasal
sinuses. The lining of  nasal cavity is very vascular.
Oral cavity:
The oral cavity is bounded by the alveolar arch and teeth
anteriorly with hard palate in the front and soft palate posteriorly. The
tongue is the chief constituent of the oral cavity, which is bounded by
the mandible and teeth. The presence of good mouth opening is essential
for many airway procedures. Initial mouth opening occurs due to the
rotation within the temporomandibular joint and the later movement
occurs due to the sliding or translocation of the condyles of the
temporomandibular joint.
Nasopharynx:
Nasopharynx is present behind the nasal cavity and is separated
from the oropharynx by the soft palate. During deglutition soft palate
prevents the regurgitation of fluid through the nose. The nasopharynx
has two important contents. One is the nasopharyngeal tonsil or the
adenoids, which is a collection of lymphoid tissue, a part of Waldeyer’s
ring . Other is the orifice of the pharyngotympanic or the auditory tube.
5Oropharynx:
The oropharynx is present behind the mouth and the tongue. It
extends from the uvula of the soft palate above to the tip of the epiglottis
below. It is bounded anteriorly by the anterior pillar of the fauces. The
chief  constituent of  the oropharynx is palatine tonsils which is one of
the constituent of Waldeyer’s ring.
Larynx:
The Larynx, which lies at the level of the third through sixth
cervical vertebra, serves as the organ of phonation and acts as a valve to
protect  the lower airways from the contents of the alimentary tract.
The structures which form its framework are the epiglottis,
thyroid cartilage, cricoid and the arytenoids. The larynx is slung from
the “U” shaped hyoid bone by the thyrohyoid membrane and thyrohyoid
muscle.
Behind the root of the tongue lies the leaf shaped elastic cartilage
called, the Epiglottis. The hyo- epiglottic ligament attatches the
epiglottis to the body of the hyoid bone anteriorly and the thyro-
epiglottic ligament connects the epiglottis to the thyroid cartilage
immediately above the vocal cords.
6The shield-like thyroid cartilage is made up of two lateral plates.
These two plates meet in the midline forming the laryngeal  prominence,
which can be easily visualized in the postpubertal male.
The only cartilage forming complete ring in the entire respiratory
tract is the cricoid cartilage. It has a signet ring shape. The cricothyroid
membrane attatches the cricoid cartilage to the trachea.
The arytenoids lies one on either side of the posterior surface of
the cricoids cartilage. At the apex of the arytenoids lies a nodule called
as corniculate cartilage and in the margins of the aryepiglottic folds lies
a flank of cartilage called the cuneiform cartilage. These are of no
functional importance.
The laryngeal inlet is bounded by the epiglottis, aryepiglottic
folds, posterior cartilage, and interarytenoid notch. The vocal cords run
between the vocal processes of the arytenoid cartilage and the posterior
surface of the thyroid cartilage. The base of the tongue is connected with
the lateral border of the epiglottis by the median and the lateral
glossoepiglottic folds. The depressions between these two folds is called
as the valleculae (often called vallecula).
7 The laryngeal muscles can be grouped according to their actions on
the vocal cords: abductors, adductors, and regulators of tension. The
posterior cricoarytenoid muscles abduct the vocal cords. The lateral
cricoarytenoid muscles adduct the vocal cords.
 The cricothyroid membrane joins the thyroid with the adjacent
cricoid cartilage. It is close to the skin, relatively avascular, and the idest
gap between the cartilage of the larynx and trachea, so it provides the
best access for percutaneous airway rescue techniques.
The trachea extends from the lower edge of the cricoid cartilage
to the carina. It consists of U-shaped cartilage joined by fibroelastic
tissue and is closed posteriorly by the longitudinal trachealis muscle.
The tracheal rings and trachealis muscle are responsible for the
characteristic endoscopic appearance of the trachea.
Nerve supply:
The cranial nerve provides sensory supply to the upper airway.
The anterior ethmoidal nerve, a branch of Ophthalmic division of the
trigeminal nerve and the Sphenopalatine nerve, a branch of  maxillary
division of the  trigeminal nerve innervates the mucous membrane of the
8nose. The superior and the inferior surfaces of the hard and soft palate
are innervated by the palatine nerves.
The general sensation of the anterior two- thirds of the tongue is
provided by the lingual nerve, a branch of mandibular division of
trigeminal nerve and taste sensation is provided by the facial nerve. The
posterior third of  the tongue is innervated by the glossopharyngeal
nerve which provides both general and taste sensation.
The roof of the pharynx, the tonsils, and the undersurface of the
soft palate are innervated by the glossopharyngeal nerve. The nerve
supply for the  airway below the glottis is provided by the vagus nerve.
Between the epiglottis and the vocal cords the sensory supply is
provided by the internal laryngeal nerve, a branch of vagus nerve and
the motor supply is provide by the external laryngeal nerve, a branch of
vagus nerve. The recurrent laryngeal nerve, a branch of vagus nerve
innervates the larynx below the vocal cords.
The recurrent laryngeal nerve innervates the muscles of the larynx
except the cricothyroid muscle which is innervated by the external
laryngeal nerve.
9Damage  to  the  nerves  innervating  the  larynx  can  lead  to  a
spectrum of disorders. Unilateral denervation of the superior laryngeal
nerve causes subtle clinical findings. Bilateral superior laryngeal nerve
palsy can lead to hoarseness of voice but the airway control is not
jeopardized.
Unilateral recurrent laryngeal nerve palsy causes paralysis of
ipsilateral vocal cord, resulting in deterioration in voice quality. Acute
bilateral recurrent laryngeal nerve palsy can result in stridor and
respiratory distress due  to the unopposed tension of the cricothyroid
muscles. Chronic bilateral recurrent laryngeal nerve palsy are associated
with aphonia  and have lesser  airway problems due to the development
of compensatory mechanisms like atrophy of the laryngeal musculature.
Bilateral vagus nerve injury affects both the superior and the
recurrent laryngeal nerves resulting in flaccid, midpositioned vocal
cords similar to those seen after administration of succinylcholine. The
phonation is severely impaired but the airway is less affected.
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Blood supply:
Branches of the thyroid artery provide blood supply to the  larynx.
The superior laryngeal artery, a branch of the superior thyroid artery, a
branch of external carotid artery supplies above the vocal folds. The
inferior laryngeal artery, a branch of inferior thyroid artery supplies
below the vocal folds.
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CLASSIC LARYNGEAL MASK AIRWAY
Classic LMA  was the first supraglottic airway device which
became available since 1989.
DEVICE DESCRIPTION:
LMA Classic is a reusable device, made up of medical grade
silicone and latex free. It can be used 40 times after autoclaving.
Classic LMA has 3 components
1. Airway tube
2. Mask
3. Mask inflation line
The airway tube has a standard 15mm Male adaptor, is a large
bore tube fitted to the mask, which has an inflatable cuff. On the distal
opening of the tube there are 2 aperture bars for preventing the epiglottis
from entering the shaft of LMA leading to obstruction. The mask design
of  LMA conforms to the contours of the hypopharynx.
CLASSIC LMA
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INDICATIONS:
1. Elective ventilation : as an alternative to endotracheal
intubation for short procedures.
2. Difficult airway: as a rescue device after failed intubation
3. Cardiac arrest: LMA is an acceptable alternative to
intubation for airway management in the cardiac arrest
patients.
4. Conduit for intubation: in difficult laryngoscopy cases
LMA has role in the management of difficult airway at 5 places,
either as:
A. Ventilatory device, or
B. As a conduit to aid tracheal intubation
The 5 places are:
1. LMA as an intubation conduit in the awake intubation limb of the
algorithm
2. LMA as an intubation conduit in the non-emergency pathway in
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3. anaesthetized patients
4. LMA  as  an  airway  device  in  the  non-emergency  pathway  in
anaesthetized patients
5. LMA as an airway device in the emergency pathway (Cannot
Ventilate- Cannot Intubate (CVCI)) of the algorithm
6. LMA as a conduit to  endotracheal intubation in the emergency
pathway (CVCI).
CONTRAINDICATIONS:
Absolute:
1. Cannot open the mouth
2. Complete upper airway obstruction
Relative
A. Increased risk of aspiration:
1. Prolonged bag mask ventilation
2. Morbid obesity
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3. Second or third trimester pregnancy
4. Not fasted before ventilation
5. Upper gastrointestinal bleeding
B. Suspected or known abnormal supraglottic airway anatomy
C. Need for high airway pressures
Classic LMA is currently available in 8 sizes
Size of the mask Weight (kg)
Max cuff inflation
volume (ml)
1 Less than 5 4
1 ½ 5 – 10 7
2 10 – 20 10
2 ½ 20 – 30 14
3 30 – 50 20
4 50 – 70 30
5 70 – 100 40
6 >100 50
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Advantages of LMA compared with face mask
1. Hands free operation
2. Better seal in bearded patients
3. Less cumbersome in ENT surgery
4. Easier to maintain airway
5. Protects against airway secretions
6. Less facial nerve and eye trauma
7. Less operating room pollution
Disadvantages of LMA compared with facemask
1. More invasive
2. More risk of airway trauma
3. Requires new skill
4. Deeper anaesthesia required
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5. Requires some temporomandibular joint mobility
6. N2O diffusion into cuff
7. Multiple contraindications
Advantages of LMA compared with tracheal intubation
1. Less invasive
2. Very useful in difficult intubations
3. Less tooth and laryngeal trauma
4. Less laryngospasm and bronchospasm
5. Does not require muscle relaxation
6. Does not require neck mobility
7. No risk of esophageal or endobronchial intubation
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Disadvantages of LMA compared with tracheal intubation
1. Increased risk of gastrointestinal aspiration
2. Less safe in prone or jack knife positions
3. Limits maximum positive pressure ventilation
4. Less secure airway
5. Greater risk of gas leak and pollution
6. Can cause gastric distention
COMPLICATIONS:
The rate of complications due to laryngeal mask insertion was
0.15 % but the rate is likely to  be higher in the emergency setting. The
complications include:
1. Aspiration of gastric contents
2. Local irritation
3. Upper airway trauma
4. Nerve palsies
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5. Mild sympathetic response
6. Obstruction due to improper placement
7. Laryngospasm
8. Pulmonary  edema and bronchoconstriction due to positive
pressure ventilation
PERFORMANCE TESTS:
Before using the device, the following inspections and tests must
be conducted in an area and in an manner consistent with accepted
medical practice that minimizes the contamination of the device before
insertion.
1. VISUAL INSPECTION:
The surface of the LMA Classic must be examined for damage
including cuts, tears, scratches or kinks. The airway tube should not be
discoloured.
The interior of the airway tube must be examined to ensure that
they are free from blockages and loose particles. If any particle is found
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it should be removed. Do not use the device if any blockage or particle
can’t be removed.
The tube should be flexed upto, but not beyond 180°. Kinking
should not occur.
The mask aperture should be gently probed to make sure that it is
free  from particulate matter.
2. INFLATION AND DEFLATION:
The cuff should be deflated completely. After deflation, check the
cuff for spontaneous inflation. If the cuff inflates spontaneously, do not
use the airway.
The cuff should be inflated with 50 % more air than the
recommended maximum inflation volume. The cuff should hold
pressure for at least 2 min. Any  herniation, wall thinning , or
asymmetry is an indication to discard the LMA.
The balloon should be elliptical, not spherical or irregularly
shaped. Excessive pilot balloon width indicates weakness and imminent
rupture.
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DEVICE INSERTION:
The posterior surface of the mask is lubricated with water soluble
jelly just prior to insertion.
Stand behind the patient’s head and place the patient’s head in the
neutral or sniffing position
The tube portion is grasped with the index finger pressing on the
point where the tube joins the mask.
With the aperture facing forward, the tip of the cuff is placed
against the inner surface of the upper incisors. The tube should be
parallel to the floor.
The mask portion is pressed against the hard palate by using index
finger.
Maintaining pressure against the palate the mask portion is
advanced. A change of direction can be sensed as the mask tip
encounters the posterior pharyngeal wall. Swing the device inward with
a circular motion, pressing against the hard and soft palate.
The device is advanced into the hypopharynx until resistance is
felt.
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DEVICE INFLATION:
The cuff should be inflated with air until relevant intra-cuff
pressure is reached. The cuff pressure should not exceed 60cm H2O.
If there is no manometer by hand, inflate with just enough air to
achieve a seal sufficient to permit ventilation without leaks.
After inflating the cuff, it should be connected to the anaesthetic
breathing circuit. The position of the LMA can be confirmed by :
? A definite end point is noted while  inserting the LMA
? While inflating the cuff the LMA rises slightly out of the
mouth.
? As the cuff is inflated the anterior neck bulges slightly
? The black line on the back of the LMA remains in the midline
? The cuff of the LMA is not visible in the mouth
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AMBU LARYNGEAL MASK AIRWAY
AMBU LMA is a recently introduced disposable supraglottic
device. It is made up of polyvinyl chloride. It is made up of 3 parts:
1. Airway tube
2. Mount area
3. Bowl with inflatable cuff
These 3 parts are moulded together in order to prevent their
separation. The airway tube has a standard 15mm Male adaptor, with the
other end connected to the mount. The airway tube, mount junction is
bent 90°, thereby conforming the anatomy of the hypopharynx, pharynx
and mouth. This angulation obviates the need of using index finger
insertion method used for inserting Classic LMA. There are 3 thickened
reinforcement bars at the bent area of the airway tube to maintain the
shape during LMA insertion.
INDICATIONS:
1. Elective ventilation : as an alternative to endotracheal intubation
for short  procedures
AMBU LMA
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2. Difficult airway: as a rescue device after failed intubation
Cardiac arrest: LMA is an acceptable alternative to intubation
for airway management in the cardiac arrest patients.
3. Conduit for intubation: in difficult laryngoscopy cases LMA
has role in the management of difficult airway at 5 places,
either as:
A. Ventilatory device, or
B. As a conduit to aid tracheal intubation
The 5 places are:
1. LMA as an intubation conduit in the awake intubation limb of the
algorithm
2. LMA as an intubation conduit in the non-emergency pathway in
anaesthetized patients
3. LMA  as  an  airway  device  in  the  non-emergency  pathway  in
anaesthetized patients
4. LMA as an airway device in the emergency pathway (Cannot
Ventilate- Cannot Intubate (CVCI)) of the algorithm
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5. LMA as a conduit to  endotracheal intubation in the emergency
pathway (CVCI).
CONTRAINDICATIONS:
Absolute:
Cannot open the mouth
Complete upper airway obstruction
Relative
A. Increased risk of aspiration:
1. Prolonged bag mask ventilation
2. Morbid obesity
3. Second or third trimester pregnancy
4. Not fasted before ventilation
5. Upper gastrointestinal bleeding
B. Suspected or known supraglottic airway anatomy
C. Need for high airway pressures
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Sizes available:
Size of the mask Weight (kg)
Max cuff inflation
volume (ml)
1 Less than 5 4
1 ½ 5 – 10 7
2 10 – 20 10
2 ½ 20 – 30 14
3 30 – 50 20
4 50 – 70 30
5 70 – 100 40
6 >100 50
Advantages of LMA compared with face mask
1. Hands free operation
2. Better seal in bearded patients
3. Less cumbersome in ENT surgery
4. Easier to maintain airway
5. Protects against airway secretions
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6. Less facial nerve and eye trauma
7. Less operating room pollution
Disadvantages of LMA compared with facemask
1. More invasive
2. More risk of airway trauma
3. Requires new skill
4. Deeper anaesthesia required
5. Requires some temporomandibular joint mobility
6. N2O diffusion into cuff
7. Multiple contraindications
Advantages of LMA compared with tracheal intubation
1. Less invasive
2. Very useful in difficult intubations
3. Less tooth and laryngeal trauma
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4. Less laryngospasm and bronchospasm
5. Does not require muscle relaxation
6. Does not require neck mobility
7. No risk of esophageal or endobronchial intubation
Disadvantages of LMA compared with tracheal intubation
1. Increased risk of gastrointestinal aspiration
2. Less safe in prone or jack knife positions
3. Limits maximum positive pressure ventilation
4. Less secure airway
5. Greater risk of gas leak and pollution
6. Can cause gastric distention
28
COMPLICATIONS
The rate of complications due to laryngeal mask insertion was
0.15 % but the rate is likely to  be higher in the emergency setting. The
complications include:
1. Aspiration of gastric contents
2. Local irritation
3. Upper airway trauma
4. Nerve palsies
5. Mild sympathetic response
6. Obstruction due to improper placement
7. Laryngospasm
8. Pulmonary  edema and bronchoconstriction due to positive
pressure ventilation.
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PERFORMANCE TESTS:
Before using the device the following inspections and  tests must
be conducted in an area and in an manner consistent with accepted
medical practice that minimizes the contamination of the device before
insertion.
1. VISUAL INSPECTION:
The surface of the AMBU LMA must be examined for damage
including cuts, tears, scratches or kinks. The airway tube should not be
discoloured.
The interior of the airway tube must be examined to ensure that
they are free from blockages and loose particles. If any particle is found
it should be removed. Do not use the device if any blockage or particle
can’t be removed.
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1. INFLATION AND DEFLATION:
The cuff should be deflated completely. After deflation, check the
cuff for spontaneous inflation. If the cuff inflates spontaneously, do not
use the airway.
Inflate the cuff with 50% more air than recommended maximum
inflation volume. The cuff should hold pressure for at least 2 min.
The cuff should hold pressure for at least 2 min. Any herniation,
wall thinning , or asymmetry is an indication to discard the LMA. The
balloon should be elliptical, not spherical or irregularly shaped.
Excessive pilot  balloon width indicates weakness and imminent rupture.
DEVICE INSERTION:
The posterior surface of the mask is lubricated with water soluble
jelly just prior to insertion.Stand behind the patient’s head and place the
patient’s head in the neutral position. The tube portion is grasped with
hand.
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With the cuff facing forward (black line facing the patient’s upper
lip), the tip of the cuff is placed against the inner surface of the upper
incisors. The tube should be parallel to the floor.
The mask portion is pressed against the hard palate by using index
finger. Maintaining pressure against the palate the mask portion is
advanced.
A change of direction can be sensed as the mask tip encounters
the posterior pharyngeal wall. Swing the device inward with a circular
motion, pressing against the hard and soft palate.
The device is advanced into the hypopharynx until resistance is
felt.
DEVICE INFLATION:
The cuff should be inflated with air until relevant intra-cuff
pressure is reached. The cuff pressure should not exceed 60cm H2O.
If there is no manometer by hand, inflate with just enough air to
achieve a seal sufficient to permit ventilation without leaks.
32
After inflating the cuff, it should be connected to the anaesthetic
breathing circuit. The position of the LMA can be confirmed by :
? A definite end point is noted while  inserting the LMA
? While inflating the cuff the LMA rises slightly out of the mouth.
? As the cuff is inflated the anterior neck bulges slightly
? The black line on the back of the LMA remains in the midline
? The cuff of the LMA is not visible in the mouth
33
REVIEW OF LITERATURE
The literature was searched and reviewed to compare the
effectiveness of LMA Classic over LMA Ambu for general anaesthesia
for elective surgeries.
1. A.B.Suzanna1, C.Y. Liu, S.W.Syed Rozaidi, J.S.M Ooi compared
the ease of insertion, adequacy of seal intraoperatively and
postoperative complications between LMA Classic and LMA
AMBU in patients undergoing elective general anaesthesia with
positive pressure ventilation.
In this study 118 ASA I & II patients scheduled to undergo
elective procedures under general anaesthesia were randomly
allocated into receiving either  LMA AMBU or the LMA Classic.
The intra operative  management was  identical in both the groups
and included induction with propofol/ fentanyl, maintenance with
sevoflurane and nitrous oxide oxygen mixture.
The time for insertion for LMA AMBU group was 35 sec and for
LMA Classic it was 40 sec signifying shorter insertion time for
LMA AMBU group. The incidence of blood staining was similar.
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It  was  13  in  Classic  LMA  group  and  it  was  8  in  LMA  AMBU
group. The incidence of sore throat was 20 in the LMA Classic
group and it was 9 in the LMA AMBU group signifying lesser
incidence of sore throat in the LMA AMBU group.
The study concluded that LMA AMBU took lesser time for
insertion and had a superior seal during positive pressure
ventilation  compared to  Classic LMA. AMBU LMA and Classic
LMA were comparable in terms of ease of insertion. (Med  J
Malaysia Vol 66 No 4 October 2011)
2. Cairn A.Hagberg2, Frank Samsoe Jensen, Harald
V.Genzwuerker, Renee Krivosic-Horber, Bettina U.Schmitz,
Jochen Hinkelbein, Marius Contzen, Herve Menu, Karim
Bourzoufi evaluated the performance and safety of the AMBU
LMA.
One hundred and eighteen patients of ASA I & II scheduled for
elective surgery with general anaesthesia were enrolled in this
study.  Anaesthesia  was induced with alfentanil 20?g/kg or
fentanyl 3.5?g/kg followed by propofol 2.5 mg/kg and maintained
with propofol and opioids without muscle relaxant.
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The study concluded that AMBU LMA was easier and  quicker to
insert and it resulted in a safer and efficient seal, during positive
pressure ventilation in non-paralized patients. (Anesth Anal
2005;101:1862-6)
3. L.Miceli3, S.Mattelig, N.Fasano, S.De Lucia, C.Savoia, G.Della
Rocca  compared Classic LMA with AMBU LMA in terms  of
insertion time and property of ventilation.
Twenty two patients of ASA I & II undergoing orthopedic
surgery were randomly allocated into two groups (group LMA
and group AMBU). Both groups received general anaesthesia
with propofol 2.5mg/kg, remifentanyl 0.05-
0.5?g/kg/min(continuous infusion) with sevoflurane without
muscle relaxant.
The insertion time was 20.7sec for group LMA and 14.4sec for
AMBU LMA group signifying less insertion time for AMBU
LMA group.  The  air  leak  was  26.1  cmH2O for group LMA and
24.0 cmH2O for AMBU LMA group.
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         The study concluded AMBU LMA had lesser time for insertion
and a valid alternative to LMA Classic. (European Journal of
Anaesthesiology:  June 2006 - Volume 23 - Issue - p 269).
4. C.Y.Wang, LL.Shariffuddin21 did a randomized comparison of
AMBU LMA with Classic LMA in paralysed anaesthetized
patients.
Forty patients of ASA  I & II status scheduled for undergoing
elective surgery under general anaesthesia were enrolled for
randomized crossover study.
The mean oropharyngeal leak pressure for AMBU LMA was 19
cmH2O which was significantly greater than Classic LMA (15
cmH2O) and the number of attempts for successful insertion was
significantly less (50% vs 56%). The time taken for insertion was
similar in both the groups.
The study concluded that both the groups were comparable with
respect to trauma to the airway, the quality of fibreoptic view,
peak airway pressures and positive pressure ventilation during
elective general anaesthesia. (Anaesthesia. 2008 Jan;63(1):82-5)
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5. C.S.Strydom9, P.J.Le Roux compared the effectiveness between
classic LMA, LMA AMBU, LMA Unique and Cobra PLA.
One hundred and fifteen patients belonging to ASA I to III were
taken into the study and were randomized to receive either Classic
LMA or one of the four disposable devices. All received
standardized anaesthesia with propofol, fentanyl and isoflurane in
40% O2/N2O.
There were no statistical differences in the number of times the
airway device had to be changed (p-0.627), ease of insertion (p-
0.357) or insertion attempts (p-0.909).
The study concluded that there was no difference between Classic
LMA, LMA Unique, LMA AMBU, Cobra PLA in terms of ease
of insertion, number of attempts, patient comfort or airway
trauma.(SAJAA 2008; 14(6): 31-36/Nov/Dec)
6. G.Sudhir16, D.Redfern, AR.Wilkes, J.E.Hall compared the
effectiveness of LMA Classic with LMA AMBU.
Forty Five patients belonging to ASA I- III were enrolled in this
cross over study. All patients received standard total intravenous
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general anaesthetic. The AMBU LMA and the Classic LMA were
inserted one after other in random order.
The study concluded that the first attempt insertion success rate
were comparable between both groups but AMBU LMA had
better ease of insertion compared to the Classic LMA.
(Anesthesia: 2005;60,664-7)
7. Kristine Faust4, Celia D’Errico, Terri Voepel-Lewis, Constance
Burke, Vincent Zuellig did a paediatric comparative study
between the AMBU LMA and the Classic LMA in terms of ease
of insertion and seal pressure.
One hundred and eighteen children aged between 2-12 yrs were
randomly allocated into two groups and received either AMBU
LMA or Classic LMA for management of the airway . All
received induction and maintenance with sevoflurane.
 The study obtained results as 100% ease of insertion for the
AMBU LMA group and 93 % for the Classic LMA group. For
AMBU LMA, the leak pressure was 21.47 compared to 20.72 for
the Classic LMA which was not significant.
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The study concluded that AMBU LMA was easier to insert
compared to the Classic LMA and was comparable and
suitable alternative for use in the children. (Anesthesia &
Analgesia, Dec 2005)
8. Harald V Genzwuerker8 compared the effectiveness between
Classic LMA and AMBU LMA  in paediatric patients undergoing
ambulatory surgery.
One hundred children of ASA I & II aged 2-8 yrs undergoing
elective ambulatory procedures were enrolled in the study and
were randomly allocated into two groups.
The study concluded that Classic LMA and AMBU LMA were
comparable with respect to the number of insertion ttempts and
the airway seal quality. (ASA 2007)
9. Gernoth.C10, Jandewerth.O, Contzen.M, Hinkelbein.J,
Genzwuerk.H.V compared the ease of insertion and the quality of
airway seal between LMA AMBU and LMA Classic in patients
with simulated cervical spine immobility.
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Sixty patients who were scheduled to undergo elective day care
procedures were randomly allocated into two groups  – ALM
(LMA AMBU) and LMC (LMA CLASSIC). Anaesthesia
management was similar in both the groups.
The time taken for insertion of the device in the  ALM  was 15.6
+/- 4.4 and in the LMC group it was 15.5 +/- 4.9 seconds. Airway
leak pressure in the ALM group were 25.6 +/- 5.2 cmH2O and for
LCM group it was 26.5 +/- 6.5 cmH2O.
The study concluded that the ease of insertion, airway seal and
post operative complaints were comparable in both the groups.
(EJA, May 2005- volume 22- Issue- p 76)
10.J.Jakobsson15, Z.Turan, A.Doolke, G.B.Saros compared the
effectiveness of Classic LMA, AMBU LMA and intersurgical
mask.
One hundred and eighty nine patients scheduled to undergo short
procedures under positive pressre ventillation were randomly
allocated into three groups to receive either LMA Classic or
AMBU LMA or intersurgical mask.
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The study concluded that the AMBU LMA was easier to use and
all the three airways, LMA Classic, AMBU LMA and
Intersurgical airway were comparable with respect to number of
attempts for first insertion and complications. (EJA, June 2007-
Volume 24- Issue – p 11-12).
11.Daryl Lindsay Williams5, James M.Zeng, Karl D. Alexander,
and David T. Andrews compared the effectiveness of AMBU
LMA with LMA Unique.
Eighty two patients were enrolled in the study and randomly
divided into two groups of LMAU group to receive LMA Unique
and  AMBU  group  to  receive  AMBU  LMA.   All  patients  a
standardized anaesthesia management.
The LMAU group had a mean cuff leak pressure of 15cm H2O
and the AMBU group had a mean cuff leak pressure of 20 cm
H2O with p = 0.001 which is statistically significant.
42
The study concluded that AMBU LMA provided better cuff leak
pressure compared to the LMA Unique. Both the airway devices
were comparable in terms of  time for insertion, success rate and
complications. (Anaesthesiology Research and Practice, Volume
2012, Article ID 405812)
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AIM OF THE STUDY
Aim of the study is to compare the effectiveness of  Classic
Laryngeal Mask Airway with AMBU Laryngeal Mask Airway in
respect to the following parameters
1. Ease of insertion of airway device
2. Number of attempts for insertion of airway device
3. Time taken for insertion of airway device
4. Hemodynamic response to Insertion
5. Blood staining of devices
6. Incidence of complications
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MATERIALS AND METHODS
It was a prospective, randomized, single-blinded, case-controlled
study conducted in the Department of Anaesthesiology, Kasturba
Gandhi Hospital, Chennai. 60 adult patients satisfying the inclusion
criteria were enrolled in the study.
INCLUSION CRITERIA:
? Age: 18 yrs and above
? Weight : BMI < 30kg/m²
? ASA : I & II
? Elective Surgery
? Mallampatti scores : I & II
? Patients given valid informed consent
EXCLUSION CRITERIA:
? Not satisfying inclusion criteria
? Patients posted for emergency surgery
? Patients with difficult airway
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? Lack of written informed consent
? Pregnant female
? History suggestive of Gastro oesophageal reflux disease/
Hiatal hernia
? Poor lung compliance such as pulmonary fibrosis
MATERIALS:
? LMA Classic 3 & 4
? LMA AMBU 3 & 4
? 20 ml syringe
? Lubricant jelly
? Drugs: glycopyrolate, fentanyl, propofol,
sevoflurane,ondansetron
? Moitors : ECG, Pulse oximetry, Capnography, NIBP
? Weighing machine calibrated to 1kg
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STUDY OUTCOME:
1. Ease of Insertion of airway device:
The ease with patient were intubated was judged subjectively on
nominal scale as “easy (1)”  and “difficult (2)”
2. No of Insertion attempts:
The no. of attempts required for successful insertion was
recorded. A “failed attempt” was defined as removal of the device
after third attempt and requiring other methods to secure the
airway.
3. Time taken for insertion:
It is defined as the time elapsed between picking up of airway
device in the hand until the presence of square wave capnography
trace.
4. Haemodynamic response:
The Heart rate and blood pressure of the patients were recorded
before insertion, 1 min after insertion, 2 min after and 5 min post
insertion of the device.
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5. End tidal carbondioxide:
The EtCO2 was measured after device insertion
6. Blood staining of the device:
The presence or absence of blood on the device was noted at the
end of surgery following removal of the device after adequate
recovery.
7. Incidence of complications:
After removal of the device following adequate recovery patients
were asked whether they experienced sore throat.
Sore throat was defined as a constant pain or discomfort in the
throat independent of swallowing.
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CONDUCTION OF THE STUDY
After obtaining institutional ethical committee clearance, all
patients scheduled for elective minor gynaecological surgeries were
screened for any comorbid illness and difficult airway. Age, height and
weight were assessed. 60 patients satisfying the inclusion criteria were
enrolled in the study. A written informed consent was obtained and the
patients were randomly allocated into two groups, LMA-C and LMA-A,
with 30 each by using closed envelop method. The size of the airway
was chosen in accordance to the manufacturers recommendations.
All patients were premedicated with Inj.glycopyrolate  0.2mg iv
in the pre anaesthesia room. The patients were shifted inside the
operating room and placed in supine position. Non invasive blood
pressure monitor, Pulse oximetry and ECG monitor were connected.
Baseline Heart rate, Blood pressure and SpO2 were recorded.
All  patients were preoxygenated with 100% oxygen at a flow rate
of 6L/min for 3 minutes by using appropriate anatomical face mask.
Patient was induced with Inj,Fentanyl 2?/kg and Inj. Propofol 2mg/kg.
Patient was ventilated with nitrous oxygen mixture 4L:4L with
sevoflurane 4% for 1 min.
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In LMA-C group, the appropriate sized LMA-Classic was
inserted in sniffing position as per manufacturers recommended
technique and is taped in position. The cuff was inflated with air. The air
inflated was enough to provide a seal which can permit ventilation
without any leaks. The  end tidal carbon dioxide trace was noted and the
initial square wave waveform was taken as an indicator of effective
ventilation.
Else,  another insertion attempt was tried after removing the
device, with a maximum of 3 attempts allowed. The ease of insertion, no
of attempts taken for successful placement and the time taken for
insertion were recorded in both the groups.
In LMA-A group, the above procedure was performed similarly.
In both groups, anaesthesia was maintained with 2% sevoflurane and
N2O: O2 at 2:1 ratio. No  muscle relaxant was used. The Heart rate and
Blood pressure were recorded 1 min after insertion, after 2 minutes and
5 minutes post insertion.
At the end of the surgery, after thorough oral suctioning, the
airway device was removed upon return of spontaneous breathing and
eye opening of the patient. After removing the airway, it was inspected
for any blood on the device which is an indication of airway trauma.
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The following complications were recorded – cough, stridor,
laryngospasm and hypoxia. Patients were evaluated for the presence of
sore throat before leaving the operating room and 2 hrs post operatively
in the recovery room.
All recorded data were analysed with SPSS software for V
Windows version 15.0. The quantitative datas were analysed by students
t-test and the qualitative data by chi-square test. Power analysis was
calculated using Minitab for windows and the power was well above the
accepted level of 80%.
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OBSERVATION AND RESULTS
This prospective, randomized, comparative, single blinded case
control study compared LMA Classic with LMA AMBU in 60 adult
females undergoing minor gynaecological surgeries.
Results are expressed as mean and standard deviation. All
statistical analyses were carried out using SPSS for windows version
15.0. The t-test was used for comparison of quantitative variants.
Qualitative variants were compared using the chi-squared test. A, ‘p’
value of less than 0.05 was considered statistically significant.
52
Table: 1 Demographic profile: Age
Group
No of
patients
Mean SD p value
LMA C 30 34.6 9.4 0.796
Not
significantLMA A 30 35.2 8.4
The mean age of group LMA C (Classic LMA) is 34.6  and group
LMA A (AMBU LMA) is 35.2 . The data is statistically not significant
(p = 0.796) and  both the groups are comparable with respect to the
demographic profile : age.
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Table: 2 Demographic profile: Weight
Group
Number of
patients
Mean SD p value
LMA C 30 53.63 7.11 0.790
Not
significantLMA A 30 54.16 7.47
The mean weight of Group LMA C is 53.63 and for Group LMA
A is 54.16.  The data is statistically insignificant (p = 0.790) and both
the groups are comparable with respect to the demographic profile :
weight.
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Table: 3 Demographic profile: Height
Group
Number of
patients
Mean SD P value
LMA C 30 152 5.41 0.416
Not
significantLMA A 30 153.1 4.97
The mean height of Group LMA C is 152 and for Group LMA A
is 153.1. The data is statistically insignificant (p = 0.416) and both the
groups are comparable with respect to the demographic profile: height.
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Table: 4 Demographic profile: BMI
Group
Number of
patients
Mean SD P value
LMA C 30 23.30 2.594 0.652
Not
significantLMA A 30 23.03 2.077
The  mean  BMI  of  group  LMA C is  23.30  and  group  LMA A is
23.03. The data is statistically not significant (p = 0.652) and both the
groups are comparable with respect to the demographic profile: BMI.
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Table: 5 Demographic profile: ASA PS Status
Group ASA I ASA II P value
Number of
patients
% Number of
patients
% 1.000
Not
significantLMA C 24 80 6 20
LMA A 24 80 6 20
In  Group  LMA  C,  24  patients  were  ASA  I  and  6  were  ASA  II
patients. In Group LMA A there were 24 patients in ASA I and 6
patients in ASA II. The data is statistically not significant (p = 1.000)
and both the groups are comparable with respect to ASA Physical
Status.
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Table: 6 Demographic profile: MPC
Group MPC I MPC II P value
Number
of
patients
%
Number
of
patients
%
1.000
Not
significant
LMA C 23 76 7 24
LMA A 23 76 7 24
23 patients in Group LMA C were MPC I and 7 patients were
MPC II. In group LMA A, 23 patients were MPC I and 7 patients were
MPC II. The data is statistically not significant (p = 1.000) and both the
groups are comparable with respect to MPC.
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Table: 7 EtCO2
Group
Number of
patients
Mean SD P value
LMA C 30 36.97 0.85 0.835
Not
significantLMA A 30 37.03 1.52
The mean EtCO2 for group LMA C is 36.97 and the mean EtCO2
for group LMA A is 37.03. Student’s t test reveals p value of 0.835
which is statistically not significant.  This indicates both the group are
comparable with respect to EtCO2  measurement.
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Table: 8 Ease of insertion of airway device
Group
Number of
patients
Easy Difficult
NO % NO %
LMA C 30 19 63 11 37
LMA A 30 27 90 3 10
p value (significant) 0.0126 0.0067
By using LMA Classic, 19 cases were inserted easily and 11 cases
were  inserted  with  difficulty.  By  using  AMBU  LMA  27  cases  ere
inserted easily and 3 cases were inserted with difficulty.
 Qualitative data values are compared by chi-square test.
Statistical analysis reveals P value of  0.0126 for easy insertion and a p
value of 0.0067 for  difficult insertion which are statistically significant.
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Table: 9 No of attempts
Group
Number
of
patients
Success in P value
1st
attempt
%
2nd
attempt
%
0.0281
significant
LMA C 30 25 83.3 5 16.7
LMA A 30 28 93.3 2 6.7
LMA Classic insertion was successful in 25/30 in first attempt
while 1 patient required second attempt. AMBU LMA insertion was
successful in 28/30 patients in the first attempt.
Statistical analysis reveals P value of 0.0281 which is statistically
significant. The two groups are statistically significant in number of
attempts required for successful insertion.
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Table: 10 Time taken for insertion
Group Number of
patients
Mean SD P value
LMA C 30 24.77 2.54 <0.001
significant
LMA A 30 15.2 2.7
The mean time taken for insertion in LMA A is 15.2 seconds and
the mean time taken for the insertion in LMA C is 24.77
seconds.Student’s t test reveals p value of < 0.001 which is statistically
significant.
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Table: 11 Haemodynamic tesponses
Table: 11a Heart Rate
Group
Number
of
patients
Mean SD P value
Baseline LMA C 30 76.9 4.52 0.586
Not
significantLMA A 30 76.2 4.53
Post
insertion
at 1 min
LMA C 30 79.2 6.6 0.085
Not
significantLMA A 30 77.0 6.2
Post
insertion
at 2 min
LMA C 30 79.8 7.4 0.123
Not
significantLMA A 30 76.8 7.6
Post
insertion
at 5 min
LMA C 30 76.6 4.9 0.014
Significant
LMA A 30 73.4 4.8
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Table: 11b Systolic Blood Pressure
Group Number
of
patients
Mean SD P value
Baseline LMA C 30 119.87 6.43 0.47
Not
significantLMA A 30 121.2 7.68
Post
insertion
at 1 min
LMA C 30 120.1 8.27 0.432
Not
SignificantLMA A 30 118.03 11.7
Post
insertion
at 2 min
LMA C 30 119.93 10.62 0.044
Significant
LMA A 30 114.17 11.04
Post
insertion
at 5 min
LMA C 30 114.5 7.03 0.043
Significant
LMA A 30 109.47 11.32
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Table: 11c Diastolic Blood Pressure
Group
Number
of
patients
Mean SD P value
Baseline LMA C 30 77.83 2.68 0.81
Not
significantLMA A 30 77.6 4.3
Post
insertion
at 1 min
LMA C 30 78.53 4.4 0.051
Not
SignificantLMA A 30 75.8 6.1
Post
insertion
at 2 min
LMA C 30 78.4 5.32 0.006
Significant
LMA A 30 73.67 7.4
Post
insertion
at 5 min
LMA C 30 76 3.67 0.001
Significant
LMA A 30 71.37 6.2
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Table: 11d Mean Arterial Pressure
Group
Number
of
patients
Mean SD P value
Baseline LMA C 30 92.1 3.9 1.000
Not
significantLMA A 30 92.1 5.1
Post
insertion
at 1 min
LMA C 30 93.0 6.3 0.063
Not
SignificantLMA A 30 89.5 8.1
Post
insertion
at 2 min
LMA C 30 93.02 7.37 0.0098
Significant
LMA A 30 87.16 9.50
Post
insertion
at 5 min
LMA C 30 88.83 4.72 0.004
Significant
LMA A 30 83.94 7.58
Heart rate, SBP, DBP and MAP were measured pre operatively
and after insertion of the LMA at 1min, 2 min and 5 min. The actual
values are documented in the tabular column.
Statistical analysis by student t test reveals p < 0.05 which is
statistically significant.
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Table: 12 Blood staining of device
Group Number
of
patients
Blood staining P value
Yes % No % 0.068
Not
significantLMA C 30 3 10 27 90
LMA A 30 2 6.67 28 93.33
Blood  staining after extubation denotes airway trauma by the
device. It occurred in 3/30 cases with LMA Classic and in 2/30 cases
with AMBU LMA.
 Statistical analysis reveals p value ( p = 0.068) which is
statistically insignificant.
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Table: 13 Incidence of sore throat
Group Number
of
patients
Sore throat P value
Yes % No % 0.462
Not
significantLMA C 30 6 20 24 80
LMA A 30 3 10 27 90
Sore throat occurred in 6 cases with LMA Classic and 3 cases
with  AMBU LMA. Statistical analysis reveals a p value (p = 0.462)
which is statistically not significant.
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DISCUSSION
AMBU LMA is a type of supraglottic airway device which is a
disposable device, better conforming to the human anatomical airway.
This study is to compare the clinical performance of  LMA
Classic with the AMBU LMA.
Ease of insertion of airway device:
Insertion of AMBU LMA was easy in vast majoriy of population.
In our study AMBU LMA is inserted with ease in 90% of patients and
Classic LMA was inserted with ease in 63 % of patients.
This is in concurrence with the study conducted by Sudhir et
al16. They compared AMBU LMA with Classic LMA as a cross over
study and found that AMBU LMA had better ease of insertion compared
to Classic LMA. Hagberg et al² conducted a multicenter study and
found that AMBU LMA was easier and quicker to insert. Kristine et al4
found that AMBU LMA scored 100 % and Classic LMA scored only 93
% in term of ease of insertion.
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Number of attempts to successful placement:
AMBU LMA was successfully inserted in 100 %  patients with
the first attempt success rate of 93.3 %. Classic LMA was successfully
inserted in 100 % with first attempt success rate of 83.3 %. The first
attempt success rate was superior for AMBU LMA compared to the
Classic LMA.
The study conducted by Suzanna et al¹ reported 87 % and 83 %
first attempt success rate for Classic LMA and AMBU LMA
respectively.  The study conducted by Genzwuerker et al8  reported 90
% and 94 % first attempt success rate with Classic LMA and AMBU
LMA respectively.
The overall success rate in many previous studies is  100 %, and
is achieved in 2 attempts.
Time taken for insertion of the airway device:
Securing  an  effective  airway  was  rapid  with  AMBU  LMA
compared with Classic LMA. The time taken for securing the airway
with AMBU LMA was 15.2 sec which was shorter than 24.77 sec taken
for the Classic LMA group.
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This was supported by Suzanna A.B et al1. The mean  insertion
time was found to be 40 sec for the Classic LMA group and 35 sec  for
the AMBU LMA group (p = 0.008).
Studies by Miceli.L3 et al and other studies conclude that  AMBU
LMA took shorter time for insertion compared to Classic LMA.
The shorter insertion time can be extremely beneficial in difficult
airway or in emergency situations.
Haemodynamic responses:
Heart rate, SBP, DBP and MAP after insertion were maintained
better  with AMBU LMA than the Classic LMA.
       This is supported by the study conducted by SY Ng et al32 .The
study concludes stating that haemodynamic instability following
insertion of either of the airway devices were similar. Many other
studies came to the conclusion that haemodynamic responses were
similar among AMBU LMA and Classic LMA.
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Blood staining:
Incidence of blood staining found on the device due  to airway
trauma is comparable among both the devices.
 Suzanna  et  al¹ evaluated the efficacy and found that blood
staining  was found in 22 % and 14 % in Classic LMA and AMBU
LMA respectively which were comparable.
Sore Throat:
Incidence of sore throat were comparable among  Classic LMA
and AMBU LMA.
Kristine Faust et al4 reported the incidence of sore  throat of 10
% in AMBU LMA group and 13 % in Classic LMA group which were
comparable.
AMBU LMA has the advantage of being a single use device.
There is an increased tendency towards single use devices due to
awareness that protein and bacteria persist on anaesthetic and surgical
instruments following decontamination and sterilization. Being a single
use device it can reduce or even eliminate this problem.
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Our study has certain limitations. First, we studied a  female
population with normal airways undergoing elective minor
gynaecological surgeries. The data collected cannot be extrapolated to
the use of LMA classic and LMA AMBU in males. Second, blinding
was not practically possible, which may be a possible source of bias.
Finally, being a single use device the cost effectiveness was not
addressed.
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SUMMARY
From this Prospective, Randomized, Comparative single blinded
case control study which evaluated the effectiveness of LMA  Classic
and AMBU LMA, it was found that.
The ease of insertion was superior for AMBU LMA compared to
the Classic LMA
Number of attempts required for successful insertion of Classic
LMA was more than that of AMBU LMA with a p = 0.028 which is
statistically significant
The time taken for insertion of AMBU LMA was shorter
compared  to Classic LMA with a p < 0.001 which is statistically
significant.
Haemodynamically there was significant difference between the
two groups with regard to heart rate, systolic blood pressure, diastolic
blood pressure and mean arterial blood pressure after insertion. AMBU
LMA was found to have better hemodynamic stability compared to
Classic LMA.
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Blood  staining  on  AMBU  LMA  and  Classic  LMA  were
comparable and was not statistically significant.
Incidence of post operative sore throat was comparable and was
not statistically significant  between AMBU LMA and Classic  LMA.
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CONCLUSION
AMBU LMA is an equally effective airway device to Classic
LMA in gynaecological surgeries. It has potential advantages like easier
and quicker to insert, better success rate at first attempt, lesser
haemodynamic response and less airway trauma.
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PATIENT CONSENT FORM
Study title :  A Prospective, randomized  study to compare the  effectiveness
of  AMBU  LMA    with  LMA  Classic  in  Gynaecological
surgeries.
Study centre: Department of Anaesthesiology,  Govt. Kasturbai Gandhi
Hospital for  Women  & Children, Chennai.
Participant name :               Age:                Sex:                I.P.No:
I confirm that I have understood the purpose of procedure for the
above study . I have the opportunity to ask the question and all my questions
and doubts have been answered to my satisfaction.
I have been explained about the pitfall in the procedure.  I have been
explained about the safety, advantage and disadvantage of the technique.
I understand that my participation in the study is voluntary and that I
am free to withdraw at anytime without giving any reason.
I understand that investigator ,regulatory authorities and the ethics
committee will not need my permission to look at my health records both in
respect to current study and any further research that may be conducted in
relation to it, even if I withdraw from the study. I understand that my identity
will not be revealed in any information released to third parties or published ,
unless as required under the law . I agree not to restrict the use of any data or
results that arise from the study .
Time:
Date:                                             Signature / thumb impression of patient
Place:                                            Patient name:
Signature of the investigator:
Name of the investigator:
GROUP LMA C
SE:NO NAME AGE IP NO Wt Ht BMI MMS ASA DIAGNOSIS PROCEDURE
1 Shanthi 29 2140 62 158 24.83 I I Primary infertiliy DHL
2 Subatra devi 25 2151 45 148 20.54 I I Primary infertiliy DHL
3 Bhuvana 33 2441 50 145 23.78 I I Primary infertiliy DHL
4 Banumathy 35 2257 68 152 29.43 I I Fibroid uterus DH
5 Revathy 22 2320 61 144 29.41 I I AUB DL
6 Rani 36 2323 44 149 19.82 I II AUB DL
7 Bakkiyalakshmi 21 2087 60 153 25.63 II I Primary infertiliy DHL
8 Sridevi 36 2086 47 149 21.17 I I Primary infertiliy DHL
9 Amudha 37 1680 58 151 25.44 I I Primary infertiliy DHL
10 Ammu 29 2487 44 143 21.52 II I Primary infertiliy DHL
11 Sangeetha 25 2881 52 156 21.37 I I Primary infertiliy DHL
12 Selvi 44 2895 46 148 21 I II Fibroid uterus DH
13 Sundari 46 2693 54 155 22.48 I I AUB DH
14 Rajeshwari 25 2481 47 149 21.17 II I Primary infertiliy DHL
15 Rani 27 2927 57 159 22.55 I I Primary infertiliy DHL
16 Kamala 43 2454 48 148 21.91 I I AUB DH
17 Periyammal 45 2636 53 149 23.87 I II AUB DH
18 Lakshmi 35 2633 49 155 20.4 I I AUB DH
19 Pachiammal 46 2696 54 159 21.36 II I AUB DH
20 Sumathi 37 2692 52 154 21.93 II I Fibroid uterus DH
21 Thara 50 2967 41 145 19.5 I II AUB DH
22 Indrani 32 2995 51 149 22.97 I I Secondary infertility DHL
23 Bharani 50 3076 58 158 23.23 I II AUB DH
24 Maheshwari 23 3072 52 143 25.43 I I AUB DH
25 Malar 40 3085 62 159 24.52 I I Fibroid uterus DH
26 Amudha 43 3149 55 154 23.19 II I AUB DH
27 Johara bee 47 2690 49 150 21.78 I II AUB DH
28 Entha 25 3136 63 161 24.3 I I Cu T Removal DH
29 Sharmila begum 17 3397 67 159 26.5 II I Rt Ovarian cyst DL
30 Daisy mary 37 3469 60 158 24.03 I I Fibroid uterus DH
GROUP LMA A
SE:NO NAME AGE IP NO Wt Ht BMI MMS ASA DIAGNOSIS PROCEDURE
1 Thulasi 26 3535 45 148 20.54 I I Primary Infertility DHL
2 Eswari 45 3624 53 156 21.78 I II Fibroid uterus DH
3 Chandhini 40 4049 60 158 24.03 II I Primary Infertility DHL
4 Shanthi 27 3858 44 151 19.3 I I Primary Infertility DHL
5 Manjula 38 3839 64 160 25 I I Primary Infertility DHL
6 Sangeetha 25 11423 48 149 21.62 I I Primary Infertility DHL
7 Nagamma 45 3980 60 159 23.73 II II AUB DH
8 Gunasundari 32 11832 45 148 20.54 I I Primary Infertility DHL
9 Hemamalini 30 4309 67 159 26.5 II I Primary Infertility DHL
10 Pattu 30 4388 47 151 20.61 I I Primary Infertility DHL
11 Anjali 25 4392 55 156 22.6 I I Primary Infertility DHL
12 Radhika 26 6481 49 150 21.78 I I Rt Ovarian cyst DH
13 Stella 40 6485 54 158 21.63 I I Fibroid uterus DH
14 Devi 38 6488 57 149 25.67 I I Fibroid uterus DH
15 Esther 34 4596 67 161 25.85 II I AUB DH
16 Kanaga 40 4612 58 159 22.94 I II Fibroid uterus DH
17 Shanthi 32 5200 53 149 23.87 I I Primary Infertility DHL
18 Gracy 33 4181 51 148 23.28 I I Primary Infertility DHL
19 Sangeetha 22 4915 59 154 24.88 II I Primary Infertility DHL
20 Selvi 29 4982 44 149 19.82 I I AUB DH
21 Alamelu 28 5046 67 159 26.5 I I AUB DH
22 Vasugi 40 3538 64 159 25.32 I II Fibroid uterus DH
23 Reethambal 36 3537 53 149 23.87 II I Fibroid uterus DH
24 Gowri 36 3619 59 151 25.88 II I Fibroid uterus DH
25 Sigamani 56 3457 47 146 22.05 I II PMB DH
26 Malliga 55 3998 57 156 23.42 I II AUB DH
27 Revathy 35 15789 55 155 22.89 I I AUB DH
28 Malar 40 4393 43 145 20.45 I I AUB DH
29 Indra 45 1685 44 146 20.64 I I AUB DH
30 Lalitha 30 1749 56 155 23.31 I I Secondary Infertility DHL
GROUP LMA  C
SE NO HEART RATE ETCO2 INSERTION ATTEMPTS TTI
Baseline 1 min 2min 5min
1 78 86 88 79 39 1 1 22
2 80 89 92 78 36 2 2 25
3 81 70 72 74 38 2 1 24
4 89 77 78 80 35 1 1 21
5 76 82 84 80 34 1 1 21
6 70 68 69 70 39 1 1 20
7 76 74 72 72 36 2 1 24
8 78 88 86 80 39 1 1 23
9 81 90 91 85 37 1 1 26
10 80 73 73 70 36 1 1 26
11 78 82 85 80 36 2 2 28
12 78 74 73 72 38 1 1 22
13 78 85 88 79 34 2 1 26
14 69 70 68 68 36 1 1 23
15 80 72 71 71 37 1 1 25
16 78 86 88 84 39 2 1 26
17 76 88 90 83 38 2 2 27
18 72 80 82 80 39 1 1 22
19 64 68 69 68 35 1 1 27
20 70 78 80 77 36 1 1 26
21 77 79 80 82 38 2 2 31
22 79 84 85 82 38 1 1 23
23 76 75 74 72 37 2 1 24
24 75 82 83 78 36 1 1 26
25 77 73 72 70 38 1 1 24
26 79 83 85 78 39 2 1 28
27 80 74 72 72 36 1 1 23
28 77 84 85 77 38 1 1 25
29 76 77 78 78 36 1 1 26
30 79 84 82 78 38 2 2 29
GROUP LMA  A
SE NO HEART RATE ETCO2 INSERTION ATTEMPTS TTI
Baseline 1 min 2min 5min
1 78 79 80 76 36 1 1 15
2 77 74 76 70 38 1 1 12
3 80 79 74 72 36 1 1 16
4 81 88 90 84 37 1 2 19
5 77 86 88 74 38 1 1 12
6 74 70 68 67 38 1 1 13
7 76 77 70 68 37 1 1 15
8 76 77 80 74 37 1 1 14
9 80 76 75 75 36 1 1 16
10 78 77 72 70 39 1 1 16
11 79 85 88 78 37 1 1 13
12 75 79 77 78 37 1 1 13
13 64 70 72 71 38 2 1 17
14 74 77 78 72 37 1 1 16
15 73 88 92 80 37 1 1 15
16 77 76 70 67 36 1 1 12
17 75 77 78 78 38 1 1 18
18 79 80 76 72 36 1 1 12
19 75 70 67 68 38 1 1 14
20 80 70 68 67 36 1 1 13
21 67 78 80 75 38 1 1 15
22 64 66 68 70 37 1 1 16
23 82 92 96 82 37 2 2 25
24 82 78 76 74 36 2 1 17
25 76 77 76 80 37 1 1 19
26 79 75 72 70 37 1 1 16
27 75 70 77 76 36 1 1 14
28 76 70 68 66 37 1 1 15
29 79 79 80 76 36 1 1 13
30 80 70 72 72 36 1 1 15
GROUP LMA C
Baseline 1 min after insertion 2 min after insertion 5 min after insertion
S NO systolic diastolic mean systolic diastolic mean systolic diastolic mean systolic diastolic mean
1 131 83 99 144 90 108 144 88 107 121 78 92.3
2 116 78 90.7 124 82 96 127 84 98.3 110 74 86
3 128 84 98.7 110 72 84.7 110 73 85.3 106 70 82
4 136 78 97.3 116 74 88 108 72 84 104 71 82
5 116 74 88 124 78 93.3 126 80 95.3 121 79 93
6 121 79 93 118 74 88.7 114 73 86.7 112 73 86
7 124 80 94.7 117 76 89.7 114 75 88 113 76 88.3
8 128 81 96.7 134 84 101 136 85 102 126 81 96
9 118 79 92 121 81 94.3 124 81 95.3 116 78 90.7
10 114 76 88.7 108 72 84 102 71 81.3 104 71 82
11 118 77 90.7 116 77 90 108 72 84 119 79 92.3
12 128 81 96.7 116 78 90.7 112 77 88.7 110 76 87.3
13 118 79 92 128 84 98.7 130 85 100 124 80 94.7
14 108 74 85.3 110 75 86.7 111 76 87.7 108 75 86
15 113 75 87.7 108 73 84.7 106 71 82.7 104 71 82
16 112 74 86.7 121 81 94.3 124 82 96 118 79 92
17 121 80 93.7 132 85 101 134 86 102 128 84 98.7
18 117 74 88.3 110 72 84.7 104 68 80 103 69 80.3
19 114 76 88.7 116 77 90 118 78 91.3 113 74 87
20 118 77 90.7 121 80 93.7 122 80 94 116 76 89.3
21 123 80 94.3 125 81 95.7 128 82 97.3 119 78 91.7
22 114 75 88 121 79 93 124 81 95.3 116 76 89.3
23 118 77 90.7 114 74 87.3 113 74 87 110 72 84.7
24 121 79 93 125 81 95.7 128 82 97.3 118 77 90.7
25 124 78 93.3 116 75 88.7 112 73 86 110 73 85.3
26 117 76 89.7 124 81 95.3 128 82 97.3 119 79 92.3
27 128 78 94.7 112 77 88.7 110 75 86.7 106 74 84.7
28 114 76 88.7 120 79 92.7 123 81 95 119 79 92.3
29 124 81 95.3 131 83 99 134 84 101 123 80 94.3
30 114 76 88.7 121 81 94.3 124 81 95.3 119 78 91.7
GROUP LMA A
Baseline 1 min after insertion 2 min after insertion 5 min after insertion
S NO systolic diastolic mean systolic diastolic mean systolic diastolic mean systolic diastolic mean
1 116 78 90.7 107 72 83.7 98 67 77.3 95 65 75
2 121 82 95 108 76 86.7 99 69 79 96 68 77.3
3 131 83 99 119 76 90.3 110 74 86 109 75 86.3
4 136 80 98.7 141 82 101.7 131 78 95.7 129 78 95
5 121 74 89.7 130 79 96 133 81 98.3 126 77 93.3
6 108 69 82 96 62 73.3 95 63 73.7 98 64 75.3
7 127 77 93.7 130 78 95.3 128 78 94.7 121 76 91
8 124 78 93.3 120 76 90.7 116 72 86.7 106 68 80.7
9 123 76 91.7 122 74 90 124 74 90.7 108 70 82.7
10 110 70 83.3 102 67 78.7 103 66 78.3 100 64 76
11 116 76 89.3 124 82 96 126 83 97.3 122 81 94.7
12 124 79 94 110 72 84.7 106 68 80.7 104 68 80
13 128 82 97.3 135 84 101 133 85 101 120 79 92.7
14 118 76 90 122 78 92.7 123 78 93 120 76 90.7
15 129 83 98.3 138 88 104.7 142 90 107.3 130 80 96.7
16 129 80 96.3 130 82 98 118 76 90 110 71 84
17 119 76 90.3 104 72 82.7 96 68 77.3 92 62 72
18 114 74 87.3 102 68 79.3 94 61 72 90 59 70
19 121 81 94.3 116 76 89.3 112 72 85.3 110 69 82.7
20 116 81 92.7 110 75 86.7 108 74 85.3 102 72 82
21 110 76 87.3 124 82 96 126 82 96.7 116 78 86.7
22 112 77 88.7 116 79 91.3 117 78 91 120 80 93.3
23 132 81 98 138 84 102 142 85 104 126 77 93.3
24 129 82 97.7 118 77 90.7 114 74 87.3 110 72 84.7
25 132 79 96.7 116 78 90.7 114 76 88.7 110 74 86
26 110 70 83.3 104 67 79.3 98 64 75.3 97 64 75
27 113 67 82.3 107 64 78.3 98 60 72.7 102 61 74.7
28 124 82 96 106 74 78 104 72 82.7 102 72 82
29 118 78 91.3 110 72 84.7 104 68 80 103 69 80.3
30 125 81 95.7 118 78 91.3 113 74 87 110 72 84.7
GROUP LMA C GROUP LMA A
S NO SORE THROAT BLOOD STAIN SORE THROAT BLOOD STAIN
1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
4 yes yes 0 0
5 0 0 0 0
6 0 0 0 0
7 0 0 yes 0
8 0 0 0 0
9 yes 0 0 0
10 0 0 0 yes
11 0 0 0 0
12 0 0 0 0
13 0 0 0 0
14 0 0 0 0
15 yes 0 0 0
16 0 0 0 0
17 0 yes 0 0
18 0 0 0 0
19 0 yes yes yes
20 0 0 0 0
21 yes 0 0 0
22 yes 0 0 0
23 0 0 0 0
24 0 0 0 0
25 0 0 0 0
26 0 0 yes 0
27 0 0 0 0
28 0 0 0 0
29 0 0 0 0
30 yes 0 0 0
PROFORMA
DATE:                                          ROLL NO:                     AIRWAY DEVICE:
NAME:
AGE:  SEX:    IP NO:
DIAGNOSIS:
SURGICAL PROCEDURE DONE:
Ht:                                               CVS:    HB:
Wt:                                              RS:
AIRWAY: MMC -                   IID     -             DENTITION -
PRE OP ASSESSMENT:
HISTORY:    Any Co-morbid illness
                     H/O Documented Difficult Airway
                      H/O previous surgeries
MEASURES OF STUDY OUTCOME:
INTUBATION RESPONSE:
                                             HR               SBP           DBP                      MAP
PRE OP:
POST INTUBATION:
1 MIN:
2 MIN:
5 MIN:
10 MIN:
EASE OF INSERTION:              EASY                                                  DIFFICULT
NO OF ATTEMPTS:
INSERTION TIME:
BLOOD STAINING OF LMA Classic/AMBU LMA:
POST OP SORE THROAT

